Illustration of DNA

STAT News

We have facilitated numerous STAT News featured articles on digital health startups, biopharma announcements, CRISPR technology, COVID-19 testing, and industry reports.

CRISPR pioneer Doudna opens lab to run Covid-19 tests

Matt Herper covers how a team of academic and industry researchers led by Jennifer Doudna, the researcher best known for her role in the discovery of the gene editing technology called CRISPR, turned a 2,500-square-foot scientific laboratory into a facility for running medical tests to detect the novel coronavirus that causes Covid-19.

Click here to read the article.

Image of Jennifer Doudna speaking

 

The Bio Revolution is changing business and society

A First Opinion piece touching upon key themes explored in McKinsey Global Institute’s research report “The Bio Revolution: Innovations transforming economies, societies, and our lives.”

Click here to read the article.

 

Following ‘CRISPR babies’ scandal, senators call for international gene editing guidelines

Andrew Joseph covers how a bipartisan trio of senators introduced a resolution underscoring their opposition to the 2018 experiments in China that led to the birth of the world’s first genome-edited babies.

Click here to read the article.

Image of Senator Dianne Feinstein

 

Patent office reopens major CRISPR battle between Broad Institute and Univ. of California

Sharon Begley covers how the U.S. patent office declared an interference between a dozen key patents awarded to the Broad Institute on the genome-editing technology CRISPR and 10 CRISPR patent applications submitted by the University of California and its partners.

Click here to read the article.

Illustration of DNA

 

GSK partners with CRISPR pioneer Doudna to search for new drugs

Matt Herper covered GlaxoSmithKline’s announcement that it would team up with some of the nation’s most prominent CRISPR researchers to use the gene-editing technology in a search for new medicines, establishing a new lab in San Francisco and spending up to $67 million over five years.

Click here to read the article.

Image of Jennifer Doudna and Jonathan Weissman in lab

 

The mark of a job well done for a CRISPR lobbyist? Silence in Congress

Nicholas Florko covers lawmakers and CRISPR companies approach to make sure experimental treatments entering the clinic are unimpeded by government bureaucracies.

Click here to read the article.

Illustration of CRISPR book in front of Congress building

 

This is a unique website which will require a more modern browser to work!

Please upgrade today!